Healthcare / Biotech
Exact Sciences
30-Second Executive Brief
Executive Assessment
Exact Sciences functions as an established institution within Healthcare / Biotech, backed by 0% sourcing coverage, though its relative influence is cooling.
- Maintains 1 mapped relationship across the graph
- 0% sourcing coverage across sourced relationships
- Tracked as established institution within the Healthcare / Biotech category
Executive Snapshot
- Strategic Role
- Established Institution
- Sourcing Coverage
- 0%
- Ecosystem Influence
- High
- Strategic Momentum
- Decelerating
View Methodology →
Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.
Coverage
- Mapped Relationships
- 1
- Technology Domains
- 2
Strategic Implications
- Central node connecting multiple strategic ecosystems
- Directly influences technology and capital flows
- Material relevance to downstream dependency mapping
Top Opportunities
Top Risks
Critical Dependencies
Cancer screening and diagnostics company, maker of the Cologuard colorectal cancer screening test, acquired by Abbott for approximately $21 billion in a deal that closed March 23, 2026, establishing Abbott as a leader in fast-growing cancer screening and diagnostics segments.
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
1 source
- Abbott Media Room — Abbott completes $21 billion acquisition of Exact Sciencescompany
Acquisition & Investment Fit
AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.
Relationship Map
The relationships surrounding Exact Sciences — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far (last 6 months)
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.
Exact Sciences's Timeline
A sourced, dated history of Exact Sciences's key moments — founding to present.
Mar 2026 · Acquired by Abbott
Abbott completed its approximately $21 billion acquisition of Exact Sciences, establishing Abbott as a leader in cancer screening and diagnostics.